» Articles » PMID: 28106685

Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies

Overview
Journal Am J Clin Oncol
Specialty Oncology
Date 2017 Jan 21
PMID 28106685
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Totally implantable venous access devices (portacaths, or "ports"), are widely used for intermittent central venous access especially for cancer patients. Although ports have a superior safety margin compared with other long-term venous access devices, there are a number of complications associated with their use.

Methods: This is a narrative review. We searched PubMed and Google Scholar for articles about complications related to the use of portacaths. "Similar articles" feature of PubMed and reference list of the existing literature were also reviewed for additional relevant studies.

Results: In this review, we provide the latest evidence regarding the most common ones of these adverse events and how to diagnose and treat them. Immediate complications including pneumothorax, hemothorax, arterial puncture, and air embolism as well as late complications such as port infection, malfunction, and thrombosis are covered in detail.

Conclusions: Physicians should be familiar with port complications and their diagnosis and management.

Citing Articles

Efficacy and Safety in the Implantation of Totally Implantable Venous Access Devices by Anesthesiologists: Perspectives From a Retrospective Oncology Cohort.

Valls N, Villablanca N, Gonzalez R, Ramirez M, Almeida C, Lopez J Cureus. 2024; 16(11):e74606.

PMID: 39735021 PMC: 11677088. DOI: 10.7759/cureus.74606.


Our Experience of 500 Chemo Port Placements with Cephalic Vein Cut Down Technique-A Saviour for Cancer Treatment.

Kumar V, Sringeri R Indian J Surg Oncol. 2024; 15(4):784-788.

PMID: 39555354 PMC: 11564418. DOI: 10.1007/s13193-024-02000-1.


Evaluation of a novel central venous access port for direct catheter insertion without a peel-away sheath.

Iguchi T, Kawabata T, Matsui Y, Tomita K, Uka M, Umakoshi N Jpn J Radiol. 2024; 43(2):282-289.

PMID: 39287917 PMC: 11790760. DOI: 10.1007/s11604-024-01658-5.


Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis.

Nunn J, Takashima M, Wray-Jones E, Raj T, Hanna D, Ullman A Support Care Cancer. 2024; 32(10):662.

PMID: 39283363 PMC: 11405478. DOI: 10.1007/s00520-024-08853-0.


Exploring factors associated with failure of totally implanted vascular access devices in a regional and rural health service: a retrospective case-control study.

Meredith C, Mander G, Thompson M, Elliott J, Reynolds L, Ng L BMJ Open Qual. 2024; 13(3).

PMID: 39117394 PMC: 11409290. DOI: 10.1136/bmjoq-2024-002799.